T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$1.3B |
| 2 |
American Airlines Group
AAL
|
+$853M |
| 3 |
Intuitive Surgical
ISRG
|
+$816M |
| 4 |
Morgan Stanley
MS
|
+$681M |
| 5 |
Wynn Resorts
WYNN
|
+$622M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$1.4B |
| 2 |
eBay
EBAY
|
+$763M |
| 3 |
DISCK
Discovery, Inc. Series C Common Stock
DISCK
|
+$760M |
| 4 |
Broadcom
AVGO
|
+$757M |
| 5 |
US Bancorp
USB
|
+$686M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 16.64% |
| 2 | Consumer Discretionary | 13.46% |
| 3 | Financials | 12.79% |
| 4 | Industrials | 12.13% |
| 5 | Technology | 9.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTRL
901
DELISTED
Control4 Corporation
CTRL
| $44.3M | 0.01% |
2,265,232
+348,114
| +18% | +$6.31M |
|
|
NATL
902
DELISTED
National Interstate Corporation
NATL
| $44M | 0.01% |
1,569,160
-4,000
| -0.3% | -$113K |
|
|
KS
903
DELISTED
KapStone Paper and Pack Corp.
KS
| $43.9M | 0.01% |
1,325,051
-27,085
| -2% | -$769K |
|
904
WD-40
WDFC
$3.09B
| $43.8M | 0.01% |
582,850
+32,252
| +6% | +$2.36M |
|
905
Simpson Manufacturing
SSD
$8B
| $43.6M | 0.01% |
1,200,240
+830
| +0.1% | +$28.2K |
|
906
Apogee Enterprises
APOG
$888M
| $43.4M | 0.01% |
1,244,560
+243,690
| +24% | +$7.59M |
|
|
CGI
907
DELISTED
Celadon Group Inc
CGI
| $43.3M | 0.01% |
2,031,980
+72,577
| +4% | +$1.64M |
|
908
Entegris
ENTG
$25B
| $43.1M | 0.01% |
3,138,152
-8,800
| -0.3% | -$104K |
|
909
Compass Diversified
CODI
$924M
| $42.9M | 0.01% |
2,366,078
-77,450
| -3% | -$1.38M |
|
|
HMHC
910
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $42.8M | 0.01% |
2,231,300
+686,600
| +44% | +$13.3M |
|
|
NCI
911
DELISTED
Navigant Consulting, Inc.
NCI
| $42.6M | 0.01% |
2,443,510
+5,032
| +0.2% | +$87.2K |
|
912
Conagra Brands
CAG
$7.39B
| $42.6M | 0.01% |
1,844,864
+1,006,823
| +120% | +$24.4M |
|
|
COBZ
913
DELISTED
CoBiz Financial,Inc
COBZ
| $42.5M | 0.01% |
3,948,297
+6,400
| +0.2% | +$67.7K |
|
|
BGC
914
DELISTED
General Cable Corporation
BGC
| $42.4M | 0.01% |
1,652,092
-97,780
| -6% | -$2.46M |
|
|
QUNR
915
DELISTED
Qunar Cayman Islands Limited
QUNR
| $42.1M | 0.01% |
1,474,613
+1,214,728
| +467% | +$31.3M |
|
|
INFA
916
DELISTED
INFORMATICA CORP
INFA
| $42M | 0.01% |
1,178,644
+7,533
| +0.6% | +$277K |
|
|
AMT.PRA
917
DELISTED
American Tower Corporation
AMT.PRA
| $41.8M | 0.01% |
+394,787
| New | +$42.3M |
|
918
Cadence Design Systems
CDNS
$89.2B
| $41.4M | 0.01% |
2,369,037
-983,410
| -29% | -$15.7M |
|
|
MJN
919
DELISTED
Mead Johnson Nutrition Company
MJN
| $41.4M | 0.01% |
443,962
-1,800
| -0.4% | -$157K |
|
|
HITT
920
DELISTED
HITTITE MICROWAVE CORP
HITT
| $41.3M | 0.01% |
530,200
-184,600
| -26% | -$11.9M |
|
921
Patterson-UTI
PTEN
$4.16B
| $41M | 0.01% |
1,173,885
+122,278
| +12% | +$4.01M |
|
922
Northrop Grumman
NOC
$81.6B
| $41M | 0.01% |
342,489
+1,900
| +0.6% | +$230K |
|
923
Badger Meter
BMI
$3.78B
| $40.9M | 0.01% |
1,552,140
+13,060
| +0.8% | +$334K |
|
924
WIX.com
WIX
$3.35B
| $40.6M | 0.01% |
2,045,438
+58,538
| +3% | +$1.11M |
|
|
ARRY
925
DELISTED
Array Biopharma Inc
ARRY
| $40.5M | 0.01% |
8,874,300
-95,600
| -1% | -$395K |
|
Similar funds
T. Rowe Price Associates's Q2 2014 Portfolio in Review
As of Q2 2014, T. Rowe Price Associates held 2,596 positions worth $463B, up 3.9% from $445B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
T. Rowe Price Associates's Q2 2014 filing shows 97 new, 1,091 increased, 793 reduced and 67 closed positions. Its largest new stake was Teva Pharmaceuticals: 4,638,481 shares worth $243M. The largest sale was Procter & Gamble, an estimated $1.4B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q2 2014 buy was Teva Pharmaceuticals: 4,638,481 shares worth $243M.
- T. Rowe Price Associates added most to Allergan Inc in Q2 2014, an estimated $1.3B increase.
- T. Rowe Price Associates's biggest Q2 2014 reduction was Procter & Gamble, cutting an estimated $1.4B.
- T. Rowe Price Associates fully exited Santander in Q2 2014, selling an estimated $134M.
- T. Rowe Price Associates's ten largest holdings make up 12% of its $463B portfolio in Q2 2014.
- T. Rowe Price Associates opened 97 new positions and closed 67 in Q2 2014.
- T. Rowe Price Associates's portfolio value rose 3.9% quarter-over-quarter to $463B.
Based on T. Rowe Price Associates's 13F filing for Q2 2014, filed 14 Aug 2014.